SebastianEduardoSattui CortesMDMS
Rheumatology • Pittsburgh, PAVasculitis
Assistant Professor of Medicine
Dr. Sattui Cortes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
580 S Aiken Ave
Ste 430
Pittsburgh, PA 15232Phone+1 412-586-3550
Summary
- Dr. Sebastian Sattui Cortes is a rheumatologist in Pittsburgh, PA and is affiliated with UPMC Presbyterian Shadyside. He received his medical degree from Cayetano Heredia University and has been in practice 4 years. He also speaks multiple languages, including Spanish and French. He specializes in vasculitis and Polymyalgia Rheumatica . He has more than 60 publications and over 1900 citings.
Education & Training
Weill-Cornell Graduate School of Medical SciencesMS, Clinical Epidemiology and Health Services Research, 2018 - 2020
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2017 - 2020
University of Alabama Medical CenterResidency, Internal Medicine, 2017
Cayetano Heredia UniversityClass of 2012
Certifications & Licensure
AL State Medical License 2016 - Present
PA State Medical License 2021 - 2024
NY State Medical License 2017 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- VCRC/VF Vasculitis Fellowship Vasculitis Foundation and Vasculitis Clinical Research Consortium
- Scholarship for Global Health Rotation University of Alabama at Birmingham - Internal Medicine Residency Program, 2017
- Claude Bennett Award - For Outstanding Housestaff Performance in the Tinsley Harrison Service University of Alabama at Birmingham - Internal Medicine Residency Program, 2017
- Join now to see all
Publications & Presentations
PubMed
- Comment on: Handgrip strength is a comorbidity marker in systemic necrotizing vasculitides and predicts the risk of fracture and serious adverse eventsSebastian E. Sattui, Sarah B. Lieber, Katherine D Wysham
Rheumatology. 2021-05-14 - 13 citationsAssociation of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.Sebastian E. Sattui, Mangala Rajan, Sarah B. Lieber, Geyanne Lui, Madeline R Sterling
Seminars in Arthritis and Rheumatism. 2021-01-05 - Reply to "Taking a stand against the politicization of medical research: How 'winging the pendulum' poses a hazard to clinical trials, study participants, and the prog...Sebastian E. Sattui, Elizabeth R. Graef, Jean W. Liew, Jeffrey A. Sparks, Alfred H.J. Kim
Expert Review of Clinical Immunology. 2021-01-02
Journal Articles
- A Randomized Trial of a Tablet Computer Informed Consent Tool Compared To a Paper Consent for an Osteoporosis StudyWarriner AH, Foster PJ, Mudano A, Wright NC, Melton ME, Sattui SE, Calmbach W, Curtis JR, Kilgore M, Lewis CE, Pace W, Saag KG, Contemporary Clinical Trial Communications, 2016
Books/Book Chapters
Abstracts/Posters
- Presentation and Clinical Features of ANCA-Associated Vasculitis in US African Americans: Experience from a Single CenterSattui SE, Westfall A, Gaffo AL, ACR /ARHP Annual Meeting 2016, Washington DC, 11/2016
- Characteristics of ANCA associated vasculitis in African American Individuals.Sattui SE, Gaffo A, UAB Department of Medicine 32nd Annual Trainee Research Symposium/, Birmingham, AL, 3/2016
- Effectiveness and feasibility of an iPad based Patient administered informed consent (IC) vs. Paper Consent for Osteoporosis Pragmatic Clinical Trials (PCT)Warriner AH, Foster PJ, Mudano A, Wright NC, Melton ME, Sattui SE, Calmbach W, Curtis JR, Kilgore M, Lewis CE, Pace W, Saag KG, ASBMR 2014, Houston, Texas, 9/2014
- Join now to see all
Authored Content
- ACR Convergence 2022: Bringing Polymyalgia Rheumatica Back to the Main StageOctober 2022
- ACR Convergence 2022: Bringing Polymyalgia Rheumatica Back to the Main StageOctober 2022
Press Mentions
Dementia more common in patients with RA receiving csDMARDs vs b/tsDMARDsDecember 7th, 2022
Sarilumab Effective for Polymyalgia Rheumatica in Phase 3 TrialNovember 21st, 2022
Ashton Kutcher Says He Has Vasculitis — Here’s What You Need to Know About This Autoimmune DisorderAugust 10th, 2022- Join now to see all
Professional Memberships
- Member
- Member
- Colegio Medico del PeruMember
Other Languages
- Spanish, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
